Position in VTRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,066,440
+$778,937 QoQ
Shares Held
885,796
-9.9% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#98
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Advisors Asset Management, Inc. holds $29,351,232 across 10 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (47.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
This page
|
885,796 | $14,066,440 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
12,119 | $6,566,437 | |
| 3 | ZTS |
Zoetis Inc.
|
51,264 | $3,683,831 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
17,488 | $2,947,427 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
24,884 | $843,069 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
24,309 | $389,673 | |
| 7 | ALKS |
Alkermes plc.
|
7,425 | $389,070 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
23,253 | $336,935 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,066,440 | 885,796 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $13,287,503 | 983,531 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,873,917 | 873,407 | Shares | Sole | 2026-08-21 | |
| 2025-09-30 | $7,198,468 | 727,118 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $6,509,121 | 728,905 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,925,099 | 680,264 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,636,611 | 774,025 | Shares | Sole | 2026-08-21 | |
| 2024-09-30 | $11,437,556 | 985,147 | Shares | Sole | 2026-08-21 | |
| 2024-06-30 | $11,760,287 | 1,106,330 | Shares | Sole | 2026-08-21 | |
| 2024-03-31 | $13,234,391 | 1,108,408 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $11,948,511 | 1,103,279 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,876,556 | 1,103,099 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,868,559 | 1,089,034 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $8,282,820 | 861,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,019,401 | 630,674 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,466,609 | 406,879 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,527,834 | 145,925 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $57,903 | 5,322 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $145,826 | 10,778 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $361,812 | 26,702 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $662,212 | 46,341 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $1,188,735 | 85,092 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $2,131,918 | 113,763 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||